Skip to main content

The need for close monitoring of early psychosis and co-occurring substance misuse

  • Carol L. M. Caton (a1)

Substance misuse is widespread among individuals with early-phase psychotic disorders and is associated with a worse illness course. Thorough assessment of patterns of substance misuse at admission for psychiatric care is often lacking and can compromise the accuracy of a diagnostic assessment that distinguishes between a primary psychosis and one that is substance induced. Given the risk to recovery from psychosis posed by substance misuse, close monitoring of the course and treatment of early-phase psychosis that is accompanied by substance misuse is indicated and could inform the development of more effective dual-diagnosis treatments.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The need for close monitoring of early psychosis and co-occurring substance misuse
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The need for close monitoring of early psychosis and co-occurring substance misuse
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The need for close monitoring of early psychosis and co-occurring substance misuse
      Available formats
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (, which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Carol L. M. Caton (
Hide All

Declaration of interest


Hide All
1 Phillips, P, Johnson, S. Drug and alcohol misuse among in-patients with psychotic illnesses in three inner-London psychiatric units. Psychiatr Bull 2003; 27: 217–20.
2 Weaver, T, Madden, P, Charles, V, Stimson, G, Renton, A, Tyrer, P, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003; 183: 304–13.
3 Van Mastrigt, S, Addington, J, Addington, D. Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 6972.
4 Barnes, TRE, Mutsatsa, SH, Hutton, SB, Watt, HC, Joyce, EM. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry 2006; 188: 237–42.
5 Mauri, MC, Vovonteri, LS, DeGaspari, IF. Substance abuse in first episode schizophrenic patients: a retrospective study. Clin Pract Epidemiol Ment Health 2006; 2: 411.
6 Barnett, JH, Werners, U, Secher, SM, Hill, KE, Brazil, R, Masson, K, et al. Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry 2007; 190: 515–20.
7 Wade, D, Harrigan, S, Edwards, J, Burgess, PM, Whelan, G, McGorry, PD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry 2006; 189: 229–43.
8 Kessler, RC, Berglund, P, Demler, O, Jin, R, Merikangas, KR, Walters, EE. Lifetime prevalence and age-of-onset of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593602.
9 Volkov, ND. Substance use disorders in schizophrenia – clinical implications of comorbidity. Schizophr Bull 2009; 35: 469–72.
10 Caton, CLM, Samet, S, Hasin, DH. When acute-stage psychosis and substance use co-occur: differentiating substance-induced and primary psychotic disorders. J Psychiatr Pract 2000; 6: 256–66.
11 Foti, DJ, Kotov, R, Guey, LT, Bromet, EJ. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatry 2010; 167: 987–93.
12 Addington, J, Addington, D. Effect of substance misuse in early psychosis. Br J Psychiatry 1998; 172 (suppl 33): s1346.
13 Turkington, A, Mulholland, CC, Rushe, TM, Anderson, R, McCaul, R, Barrett, SL, et al. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry 2009; 195: 242–8.
14 Schuckit, MA. Drug and Alcohol Abuse, 3rd edn. Plenum Publishing, 1989.
15 Satel, SL, Edell, WS. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry 1991; 148: 1708–11.
16 McLellan, AT, Woody, GE, O'Brien, CP. Development of psychiatric illness in drug abusers: possible role of drug preference. N Engl J Med 1979; 301: 1310–4.
17 Angrist, B. Amphetamine psychosis: clinical variations of a syndrome. In Amphetamine and its Analogs (eds Cho, AK, Segal, DS): 387414. Academic Press, 1994.
18 Bowers, MB, Swigar, ME. Vulnerability to psychosis associated with hallucinogen use. Psychiatry Res 1983; 9: 91–7.
19 D'Souza, DC, Perry, E, MacDougall, L, Ammerman, Y, Cooper, T, Wu, YT, et al. The psychotomimetic effect of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacol 2004; 29: 1558–72.
20 Koskinen, J, Lohonen, J, Koponen, H, Isohanni, M, Miettunen, J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 2010; 36: 1115–30.
21 Minozzi, S, Davoli, M, Bargagli, AM, Amato, L, Vecchi, S, Perucci, CA. An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. Drug Alcohol Rev 2010; 29: 304–17.
22 Arseneault, L, Cannon, M, Witton, J, Murray, RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004; 184: 110–7.
23 Semple, DM, McIntosh, AM, Lawrie, SM. Cannabis as a risk factor for psychosis; systematic review. J Psychopharmacol 2005; 19: 187–94.
24 Henquet, C, Murry, R, Linszen, D, van Os, J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31: 608–12.
25 Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, et al. Cannabis use and the risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319–28.
26 McGrath, J, Welham, J, Scott, J, Varghese, D, Degenhardt, L, Hayatbakhsh, MR, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry 2010; 67: 440–7.
27 Di Forti, M, Morgan, C, Dazzan, P, Pariante, C, Mondelli, V, Marques, TR, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry 2009; 195: 448–91.
28 Ley, A, Jeffery, D, Ruiz, J, McLaren, S, Gillespie, C. Underdetection of comorbid drug use at acute psychiatric admission. Psychiatr Bull 2002; 26: 248–51.
29 Caton, CLM, Hasin, DS, Shrout, PE, Drake, RE, Dominguez, B, First, MB, et al. Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Br J Psychiatry 2007; 190: 105–11.
30 Mathias, S, Lubman, DI, Hides, L. Substance-induced psychosis: a diagnostic conundrum. J Clin Psychiatry 2008; 69: 358–67.
31 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Text Revision (DSM-IV-TR). APA, 2000.
32 World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Version for 2007: Ch. 5, F00-F99. WHO, 2007 (
33 Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975–83.
34 Crebbin, K, Mitford, E, Paxton, R, Turkington, D. First episode drug-induced psychosis: a medium term follow up study reveals a high-risk group. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 710–5.
35 Dawson, R, Green, AI, Drake, RE, Lavori, PW, McGlashan, TH, Schanzer, B. An adaptive treatment strategy paradigm for longitudinal treatment research using substance-induced psychosis as an example. Psychopharmacol Bull 2008; 41: 5167.
36 Drake, RE, Caton, CLM, Xie, H, Hsu, E, Gorroochurn, P, Samet, S, et al. A prospective 2-year study of emergency department patients with early-phase primary psychosis or substance-induced psychosis. Am J Psychiatry 2011; 31 Mar (doi: 10.1176/appi.ajp.2011.10071051).
37 Schanzer, MB, First, MB, Dominguez, B, Hasin, DS, Caton, CLM. Diagnosing psychotic disorders in the emergency department in the context of substance use. Psychiatr Serv 2006; 57: 1468–73.
38 Hall, W, Degenhardt, L. What are the policy implications of the evidence on cannabis and psychosis? Can J Psychiatry 2006; 51: 566–74.
39 Miller, WR, Rollnick, S. Motivational Interviewing: Preparing People for Change. Guilford Press, 2002.
40 National Institute on Drug Abuse. A Cognitive Behavioral-Approach: Treating Cocaine Addiction. NIDA (
41 Burns, T, Firn, M. Assertive Outreach in Mental Health: A Manual for Practitioners. Oxford University Press, 2002.
42 Tyrer, P, Weaver, T. Desperately seeking solutions: the search for appropriate treatment for comorbid substance misuse and psychosis. Psychiatr Bull 2004; 28: 12.
43 Johnson, S, Thornicroft, G, Afuwape, S, Leese, M, White, IR, Hughes, E, et al. Effects of training community staff in interventions for substance misuse in dual diagnosis patients with psychosis (COMO study). Cluster randomised trial. Br J Psychiatry 2007; 191: 451–2.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 1758-3209
  • EISSN: 1758-3217
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 1
Total number of PDF views: 6 *
Loading metrics...

Abstract views

Total abstract views: 38 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 16th July 2018. This data will be updated every 24 hours.

The need for close monitoring of early psychosis and co-occurring substance misuse

  • Carol L. M. Caton (a1)
Submit a response


No eLetters have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *